MedTrace Logo

Serum IGF-II and Cancer: Can IGF II Levels be Used to Monitor and Screen Patients Specifically for Cervical Cancer

NCT01371695 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 60

Last updated 2011-06-13

No results posted yet for this study

Summary

The purpose of this study is to determine whether Insulin-like Growth Factor II is elevated sufficiently to detect Cervical Intraepithelial Neoplasia II (CIN II), Cervical Intraepithelial Neoplasia III (CIN III), and cervical cancer.

Conditions

  • Cervical Cancer
  • Cervical Intraepithelial Neoplasia II
  • Cervical Intraepithelial Neoplasia III

Sponsors & Collaborators

  • Onconix, Inc

    lead INDUSTRY

Eligibility

Min Age
18 Years
Max Age
75 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2011-05-31
Primary Completion
2011-09-30
Completion
2013-09-30

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01371695 on ClinicalTrials.gov